More Than 90% of Chinese Diabetic Patients Fail to Meet the Standard of "Three Highs"

At the 16th National Academic Conference of the Diabetes Branch of the Chinese Medical Association, Co-Chairman of the 3B Research Expert Committee, Vice Chairman of the International Diabetes Federation, Chairman of the Diabetes Branch of the Chinese Medical Association, and Professor Ji Liongong, Director of the Endocrinology Department of Peking University People's Hospital, appealed: The situation of comprehensive prevention and control of diabetes in China is very serious. Diabetes standard treatment plan needs to be transferred from the "glucose-centric" management model to "blood pressure, blood lipids, blood glucose" integrated management and control model to reduce the risk of cardiovascular disease in diabetic patients.

"Three-high" diabetic patients have a 2-4 times higher risk of cardiovascular disease

According to the “Guideline for the prevention and treatment of type 2 diabetes in China in 2012”, the incidence of complications in type 2 diabetes in China is high, and the main cause of disability and death is cardiovascular disease. A study in Framingham, United States, showed that the risk of cardiovascular disease in diabetic patients with hypertension and hyperlipidemia was 2-4 times higher than that of diabetic patients without blood pressure or dyslipidemia.

3B study found that in patients with type 2 diabetes, only 27.9% of patients with diabetes alone, diabetes with hypertension accounted for 30.1%, diabetes with dyslipidemia accounted for 12.2%, while suffering from diabetes, hypertension The "three high" patients with dyslipidemia accounted for 29.7%. This shows that there are currently more than 70% of diabetic patients with "two highs" or "three highs." However, in the face of such difficulties, the current status of comprehensive prevention and control of diabetes is not optimistic. In accordance with the criteria set by the Comprehensive Control Target for the 2010 China Type 2 Diabetes Prevention and Control Guideline, more than half of the diabetic patients participating in the survey have failed to control their blood glucose levels, and only 5.6% had blood pressure, blood lipids, and blood glucose levels. Level control at the same time.

Nearly 60% of patients without antihypertensive treatment 80% without fat-regulating treatment

It is reported that in the 3B study to understand the current status of diabetes, "blood pressure, blood lipids and blood glucose" compliance, but also a comprehensive observation of the current clinical treatment of the "three high" level of the treatment model, found that: 9.3% of patients attending outpatients with diabetes Did not receive any form of glycemic control therapy; only 42.9% of diabetic patients received antihypertensive therapy, 23.1% of diabetic patients received lipid-lowering therapy, and anti-hypertensive and lipid-lowering treatment modes were different from guideline recommendations. Big.

In order to further observe the occurrence of cardiovascular events and diabetic complications in patients whose blood pressure, blood lipids, and blood glucose levels did not meet the standard, 3B Research conducted an extension program. The project selected 5,000 patients with at least 2 cardiovascular risk factors from the 3B study and conducted a non-intervention follow-up for 3 years. In the completed 12-month observation, the proportion of patients with cardiovascular and cerebrovascular events was 3.5%, while the proportion of diabetic microvascular and macrovascular complications was 8.1%.

"If we don't intervene early on blood pressure, blood lipids, and blood glucose levels in diabetic patients, it will greatly increase the incidence of cardiovascular and cerebrovascular diseases, pose a serious threat to the life and quality of life of patients, and at the same time, it will also cause heavy burden on families and society. The economic burden.” An analysis of Professor Ji Li-nong said that he also called on all sectors of the community to pay attention to each other, work together, through the government's policy guidance, targeted education and training for grass-roots doctors, and development of community health services; Both parties involved in the promotion of diabetes treatment and comprehensive intervention to delay and prevent the occurrence and development of diabetic complications.